Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 29, 2017 - Issue 6
452
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Lethal concentration of perfluoroisobutylene induces acute lung injury in mice mediated via cytokine storm, oxidative stress and apoptosis

, , , , , , & show all
Pages 255-265 | Received 16 Apr 2017, Accepted 17 Jul 2017, Published online: 01 Aug 2017
 

Abstract

Perfluoroisobutylene (PFIB) is a highly toxic gas that targets the lungs. Low-level inhalation of the gas can lead to acute lung injury (ALI), pulmonary edema and even death. No specific anti-PFIB drugs are currently available and the pathogenesis of PFIB-induced ALI is not fully understood. Early direct oxidative injury and a secondary hyper-inflammatory response are recognized as the primary mechanisms of PFIB-induced ALI. In the present study, our data demonstrate for the first time that a cytokine storm is associated with PFIB-induced ALI. Levels of 10 pro-inflammatory cytokines and one anti-inflammatory cytokine were significantly increased in lung tissues of PFIB-exposed mice. PFIB inhalation additionally led to significant oxidative stress in lung tissue. Inflammation-associated CD11b+Ly6G+Ly6Cint neutrophils and CD11b+Ly6G-Ly6Chi monocytes were significantly increased in blood in association with PFIB-induced ALI. Bcl-2/Bax-mediated lung cell apoptosis was significantly increased at 1 h, followed by a sustained decrease after 1 h, which was significant at 4–8 h in PFIB-exposed mice. This suppression of apoptosis is possibly associated with the Akt-signaling pathway.

Acknowledgements

We wish to thank the Department of Pathology, 210th Hospital of the Chinese People’s Liberation Army for histopathologic analysis.

Disclosure statement

The authors report no conflicts of interest.

Additional information

Funding

This work was supported by the China Postdoctoral Science Foundation [No. 2015M572801]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.